Humira or Adalimumab, is a drug used to reduce inflammation in the body caused by rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, hidradenitis suppurativa. It must be administered under medical supervision, it is injectable and the injection sites are the abdomen and thighs, patients can self-inject only if the doctor qualifies them for this. Its presentation for sale is a container that contains two syringes pre-filled with the dose indicated to the patient.
Although it is recommended to vary the place of exposure of the injection, since the injected places can present pain, bruises, tenderness to the touch, stinging, redness, hardening; Special care must be taken and constantly checking the area and looking for particles in the form of balls or that the color changes very drastically immediately after the dose is injected, it should not be mixed with other drugs, nor should it be used again the syringe for a new dose, if there is excess content in the container, it must be voted since once opened the sample is contaminated.
They are used in patients over 65 years of age and younger, but in children and adolescents it is not yet allowed due to its side effects, in people over 75 years of age special care and constant medical attention should be taken, especially if they are patients. geriatric. Its side effects are strong, varied and fatal, in some cases they cause neoplasia and frequent serious infections, especially if they are adults over 75 years of age, a rare type of cancer (lymphomas) that grows rapidly and causes death can develop, they decrease the good cells of the bloodpreventing it from clotting or being able to fight different infections, frequent high fevers, sudden sweats, weight loss such as fatigue, lack of appetite, stomach pain, frequent urination or the lack of it, such as changing the color and odor of the itself, bleeding easily, or jaundice either only in the eyes or all over the body (yellowing of the skin).
